80 Pola-BR appeared to benefit patients regardless of COO, with a slight trend toward enhanced efficacy in ABC.
also in 4,078 other papers
Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.